arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

NEPHROS INC

NEPH
$4.26 ▲ +0.66 (+18.47%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
65 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

NEPHROS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $45.4M
Dividend Yield
Revenue Growth 6.9%
Op. Margin 1.9%
ROIC None
FCF / Share $-0.16
Trailing P/E 426.0x
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.21M
↑ +6.9%
Net Income Profit after all expenses
$140.00K
↓ -74.9%
Operating Margin Operating profit as % of sales
1.9%
↑ +388.9% 46th
FCF / Share Free cash flow per share
$-0.16
↓ -1781.7%
Long-Term Debt Long-term obligations
$141.00K
↓ -32.9%

Health Breakdown

Profitability
52
Financial Health
99
Cash Quality
78

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters